Green Lifescience Co., Ltd. (KOSDAQ:114450)

Market Cap	56.53B
Revenue (ttm)	27.76B
Net Income (ttm)	-1.95B
Shares Out	19.53M
EPS (ttm)	-102.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	931,136
Average Volume	287,118
Open	2,750.00
Previous Close	2,755.00
Day's Range	2,740.00 - 2,980.00
52-Week Range	1,450.00 - 4,640.00
Beta	1.48
RSI	55.05
Earnings Date	Nov 14, 2025

About Green Lifescience

Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbony...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2005
• Employees: 70
• Stock Exchange: KOSDAQ
• Ticker Symbol: 114450